Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Clinical High-Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06935136
What this trial is testing

Study to Evaluate the Efficacy and Safety of Axicabtagene Ciloleucel Injection as First-Line Therapy of High-Risk Large B-Cell Lymphoma

Who this might be right for
CAR-T Cell TherapyHigh-risk Large B-cell Lymphoma (LBCL)
Ruijin Hospital 60
Testing effectiveness (Phase 2)Looking for participantsNCT06467799
What this trial is testing

Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC

Who this might be right for
Hepatocellular CarcinomaBeyond Milan Criteria
Sun Yat-sen University 39
Not applicableLooking for participantsNCT07718464
What this trial is testing

FST Analysis Supporting Timely Therapy and Risk Assessment Via Clinical Decision Support for Kids

Who this might be right for
Acute Kidney InjuryRenal Replacement TherapyPediatric Intensive Care Unit
Children's Hospital Medical Center, Cincinnati 120
Large-scale testing (Phase 3)Study completedNCT00887536
What this trial is testing

A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,613
Not applicableLooking for participantsNCT06672302
What this trial is testing

A Prospective Study to Develop and Clinically Validate an in Vitro Diagnostic Medical Device That Uses Blood to Classify Patients at High Risk for Breast Cancer

Who this might be right for
Breast Neoplasm
EXoPERT 330
Testing effectiveness (Phase 2)Ended earlyNCT02557945
What this trial is testing

Gabapentin in Patients at Clinical Risk for Psychosis

Who this might be right for
Clinical High Risk for Psychosis
New York State Psychiatric Institute 9
Not applicableNot Yet RecruitingNCT06532019
What this trial is testing

Clinical Study of Active Intervention in High-risk HFpEF Patients

Who this might be right for
Heart Failure With Preserved Ejection Fraction
Xiangtan Central Hospital 924
Not applicableUnknownNCT05947019
What this trial is testing

Efficacy and Safety of Low-Level Monochromatic Red-Light for High Myopia Control in Adults

Who this might be right for
High Myopia
Shanghai Eye Disease Prevention and Treatment Center 60
Testing effectiveness (Phase 2)Study completedNCT00291694
What this trial is testing

Protocol for Women at Increased Risk of Developing Breast Cancer

Who this might be right for
Breast Cancer
Carol Fabian, MD 72
Not applicableUnknownNCT01608607
What this trial is testing

Meta-analysis of Fructose-Containing Sugar Sweetened Beverages (SSBs) and Weight Change

Who this might be right for
OverweightObesityDiabetes+3 more
John Sievenpiper 1
Not applicableUnknownNCT02389023
What this trial is testing

Comparison of Prevena Negative Pressure Incision Management System vs. Standard Dressing After Vascular Surgery

Who this might be right for
Peripheral Artery DiseaseCritical Limb IschemiaClaudication
University of Vermont Medical Center 242
Not applicableStudy completedNCT02186223
What this trial is testing

The Angel® Catheter Pivotal Clinical Trial

Who this might be right for
Pulmonary EmbolismDeep Vein ThrombosisVenous Thromboembolism+1 more
BiO2 Medical 172
Not applicableActive Not RecruitingNCT06737263
What this trial is testing

Comparison of BioHPP (High Performance Polymer) - vs Titanium- vs Zirconia Abutments

Who this might be right for
Peri-implant Soft Tissue Healing
Medical University of Graz 60
Not applicableNot Yet RecruitingNCT07372521
What this trial is testing

Measuring Small-Airways Disease Improvement After Step-up to Extrafine TRIple or High-dose ICS/LABA in Patients Uncontrolled on Medium Dose ICS/LABA eXploring T2 Inflammation

Who this might be right for
Asthma
University Hospital, Ioannina 130
Not applicableStudy completedNCT03087721
What this trial is testing

High-intensity Interval, Low Volume Training in Metabolic Syndrome

Who this might be right for
Metabolic SyndromeInsulin Resistance
Universidad de Antioquia 60
Not applicableUnknownNCT04504058
What this trial is testing

Construction of Nutritional Path for Mental Diseases

Who this might be right for
Clinical High-risk
Shanghai Mental Health Center 100
Testing effectiveness (Phase 2)UnknownNCT01991158
What this trial is testing

GAD-M Regimen As First-Line Treatment in Untreated Extranodal NK/T Cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma, Nasal Type
Sun Yat-sen University 30
Large-scale testing (Phase 3)Active Not RecruitingNCT03711032
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)

Who this might be right for
High-risk Non-muscle Invasive Bladder Cancer
Merck Sharp & Dohme LLC 1,397
Testing effectiveness (Phase 2)UnknownNCT04989855
What this trial is testing

Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score

Who this might be right for
Locally Advanced Rectal Cancer
Sun Yat-sen University 48
Post-approval studies (Phase 4)Looking for participantsNCT06609304
What this trial is testing

Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

Who this might be right for
Lymphoma, B-Cell
Zhengzhou University 20
Next Page